Enteroviruses as a possible cause of hypertension, dilated cardiomyopathy (DCM) and hypertensive heart failure (HHF) in south western Nigeria

African Health Sciences

Volumn 13, Issue 4, 2013, Pages 1098-1106

  Okonko, Iheanyi O ^a   Adebiyi, A A ^b   Ogah, O S ^c   Adu, F D ^b  

^a UNIVERSITY OF PORT HARCOURT   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

^c UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Coxsackieviruses; Dilated cardiomyopathy (DCM); Echoviruses; Enteroviruses; Etiology; Hypertension; Hypertensive heart failure (HHF)

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; CARDIOMYOPATHY, DILATED; CASE CONTROL STUDY; COMPLICATION; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; FECES; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; NIGERIA; POLIOMYELITIS; POLIOMYELITIS VIRUS; RISK FACTOR; SEROTYPING; VIROLOGY;

ADULT; AGE DISTRIBUTION; AGED; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; FECES; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NIGERIA; POLIOMYELITIS; POLIOVIRUS; RISK FACTORS; SEROTYPING;

EID: 84893908775     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: 10.4314/ahs.v13i4.34     Document Type: Article

References (47)

1. Melnick JL. Enterovir uses: Poliovir uses, coxsackieviruses, echoviruses and newer enteroviruses in: Fields virology. Fields BN, Knipe DM, Melnick JL, Chanock RM, Roizmann B, Shope RE (Ed.) New York: Raven press. 1985, 739-794
2. Modlin JF. Coxsackiviruses, echoviruses and newer enteroviruses in: Principles and practice of infectious diseases. Mandel GL, Bennett JE, Dolin R (Ed.). New York: Churchill Livingstone. 1995, 1620-1636
3. Falase AO, Fabiyi A, Odegbo-Olukoya OO. Coxsackie B viruses and heart muscle diseases in Nigerian adults. Trop. Geog. Med 1978; 31; 237-243.
4. Falase AO, Sekoni GA, Adenle AD. Dilated cardiomyopathy in young adult Africans, sequel to infections? African Journal of Medical Science 1982; 11: 1-5
5. Yoon JW. The roll of viruses and environmental factors in the induction of diabetes. Carr. Top Environ. Microbiology 1990; 164: 95-123
6. Shariff Mk, Hemtages R and Ciard M. Intrathecal Immune response in patients with the post-poliosyndrome. New England Journal of Medicine 1991; 325: 749-755.
7. Woodal CJ, Riding MH and Clements GB. Sequences specific for enteroviruses detected in spiral cord from patients with motor neurone disease. British Medical Journal 1994; 308; 1541-1543
8. Clements Gb, Mcgarry F, Naim C. et al. The detection of enterovirus specific RNA in serum the relationship to chronic fatique. J. Med. Virol 1995; 45: 151-166
9. Pallansch MA, Roos RP. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Knipe Dm, Howley PM, Griffin DE, Lamb RA, Martin MA, Riozman B, Straus SE, editors. Fields virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001; p723-775.
10. Baboonian C, Davies MJ, Booth JC, McKenna WJ. Coxsackie B viruses and human heart disease. Curr Top Microbiol Immunol 1997; 223:31-52.
11. Li Y, T Peng, Y Yang, C Niu, L Archard, and H Zhang. High prevalence of enteroviral genomic sequences in myocardium from cases of endemic cardiomyopathy (Keshan disease) in China. Heart 2000; 83(6): 696-701.
12. Andreoletti L, Bourlet T, Moukassa D, Rey L, Hot D, Li Y, Lambert V, et al. Enteroviruses can persist with or without active viral replication in cardiac tissue of patients with end-stage ischemic or dilated cardiomyopathy. J. Infect. Dis 2000; 182 (4), 1222-1227.
13. Chapman NM, KS Kim, KM Drescher, K Oka, S Tracy. 52 terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart. Virology, 2008 (in press) YVIRO- 04622; No. of pages: 12; 4C: 2
14. Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation 2006; 113: 876-890.
15. Heymans S. Myocarditis and heart failure: need for better diagnostic, predictive, and therapeutic tools. European Heart Journal 2007; 28(11):1279-1280
16. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 2006; 114:1581-1590.
17. Heymans S, Pauschinger M, De Palma A, Kallwellis-Opara A, Rutschow S, Swinnen M, et al. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis. Circulation 2006; 114:565-573.
18. Maekawa Y, Ouzounian M, Opavsky MA, Liu PP. Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity. Circulation, 2007; 115:5-8.
19. Caforio ALP, Calabrese F, Angelini A, Tona F, Vinci A, Bottaro S, Ramondo A, et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart Journal 2007; 28:1326-1333.
20. Pauschinger M, Doerner A, Kuehl U, Schwimmbeck PL, Poller W, Kandolf R, Schultheiss HP. Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 1999; 99: 889-895.
21. Kuhl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HP. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 2005a; 112:1965-1970.
22. Tschöpe C, Bock CT, Kasner M, Noutsias M, Westermann D, Schwimmbeck PL, et al. Heart Failure-High Prevalence of Cardiac Parvovirus B19 Infection in Patients With Isolated Left Ventricular Diastolic Dysfunction. Circulation 2005; 111:879-886.
23. Kuhl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with 'idiopathic' left ventricular dysfunction. Circulation 2005b; 111:887-893.
24. Schiff GM, Sherwood JR. Clinical activity of pleconaril in an experimentally induced coxsackievirus A21 respiratory infection. J. Infect. Dis 2000; 181:20-26.
25. Romero JR. Pleconaril: a novel antipicornaviral drug. Expert Opin. Investig. Drugs 2001; 10:369-379.
26. Rotbart HA, Webster AD. Treatment of potentially life threatening enterovirus infections with pleconaril. Clin. Infect. Dis 2001; 32:228-235.
27. Elfaitouri A, Nahla M, Jan Fohlman RA, Gun F, Göran F, Lars M, Jonas B. Quantitative PCR- Enhanced Immunoassay for Measurement of Enteroviral Immunoglobulin M Antibody and Diagnosis of Aseptic Meningitis. Clinical and Diagnostic Laboratory Immunology 2005; 12(2): 235-241
28. World Health Organization (WHO). Manual for the Virological Investigation of Poliomyelitis. Geneva, Switzerland: World Health Organization, 2004.
29. Ferreira Junior AG, Ferreira SMAG, Gomes MLC, Linhares ACT. Enteroviruses as a possible cause of myocarditis, pericarditis and dilated cardiomyopathy in Belum, Brazil. Brazilian Journal of Med. Biol. Res 1995; 28(8):869-874.
30. Muir P, F Nicholson, SJ Illavia, TS McNeil, JF Ajetunmobi, H Dunn, WG Starkey, KN Reetoo, N RB Cary, J Parameshwar, JE Banatvala. Serological and molecular evidence of enterovirus infection in patients with end-stage dilated cardiomyopathy. Heart 1996;76:243-249
31. Rey L, Valérie Lambert, Pierre Wattré, Laurent Andréoletti. Detection of enteroviruses ribonucleic acid sequences in endomyocardial tissue from adult patients with chronic dilated cardiomyopathy by a rapid RT-PCR and hybridization assay. Journal of Medical Virology 2001; 64(2): 133-140
32. Why HJ, Meany BT, Richardson PJ, Olsen EG, Bowles NE, Cunningham L, Freeke CA, Archard LC. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 1994; 89: 2582-2589.
33. Omonayajo TB. Isolation and Identification of Enteroviruses in Non-Polio AFP in Nigeria. An M.Sc. Project in the Dept. of Virology, University of Ibadan, Nigeria, 2002; 96p
34. Honeyman, M. How robust is the evidence for viruses in the induction of type 1 diabetes? Current Opinion Immunology 2005; 17(6): 616-623.
35. Ajabaluku OV. Isolation of Coxsackieviruses from Hypertensive Patients with Heart Failure. An M.Sc. Project in the Dept. of Virology. University of Ibadan, Nigeria, 2006; 81p
36. Adejokun AT. Isolation of Enteroviruses in Patients Presenting with Dilated Cardiomyopathy. An M.Sc. Project in the Dept. of Virology. University of Ibadan, Nigeria 2006; 77p
37. Skarsvik S, Puranen J, Honkanen J. Decreased in vitro type 1 immune response against coxsackie virus B4 in children with type 1 diabetes. Diabetes 2006; 55(4): 996-1003.
38. Trallero G, Casas I, Tenorio A, Echevarria JE, Castellanos A, Lozano A, Brena PP. Enteroviruses in Spain: virological and epidemiological studies over 10 years (1988-97). Epidemiol Infect 2000; 124(3):497-506.
39. Wenner HA, Abel D, Olson LC, Burry VF. A mixed epidemic associated with echoviruses types 6 and 11. Virologic clinical and epidemiologic studies. Am J Epidem 1981; 114:369-378
40. Antia AU, Cockshott WP, Thorpe GJ. Idiopathic cardiomegaly in Nigeria Children. British Heart Journal 1969; 2:178-183.
41. Figulla HR, Stille-Siegerer M, Mall G, Heim A, Kreuzer H. Myocardial enterovirus infection with left ventricular dysfunction: a benign disease compared with idiopathic dilated cardiomyopathy. J. Am. Coll. Cardiol 1995; 25:1170-1175.
42. Grumbach IM, Heim A, Pring-Akerblom I, Vonhof S, Hein WJ, Muller G, Figulla HR. Adenoviruses and enteroviruses as pathogens in myocarditis and dilated cardiomyopathy. Acta Cardiol 1999; 54:83-88.
43. Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 2003; 107: 857-863.
44. Fujioka S, Koide H, Kitaura Y, Duguchi H, Kawamura K. Coxsackieviruses B pathogenic role in progression of dilated cardiomyopathy. Am. Heart J 1995; 131 (4):760-765
45. Fujioka S, Kitaura A, Deguchi H, Kawamura K, Isomura T, Suma H, Shimizu A. Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy. J. Am. Coll. Cardiol 2000; 36:1920-1926.
46. Bowles NE, Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, et al. Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults. J. Am. Coll. Cardiol 2003; 42:466-472
47. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, et al. Randomized, placebo- controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 2001; 104:39-45.